SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

24.25p
   
  • Change Today:
      0.25p
  • 52 Week High: 25.00
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 231.98m
  • Volume: 1,273,246
  • Market Cap: £56.25m
  • Beta: 0.02

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 24.25p
Change Today 0.25p
% Change 1.04 %
52 Week High 25.00
52 Week Low 8.50
Volume 1,273,246
Shares Issued 231.98m
Market Cap £56.25m
Beta 0.02

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average
95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average
Price Trend
93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
47.28% above the market average47.28% above the market average47.28% above the market average47.28% above the market average47.28% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

SBTX Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
16:30 100,000 @ 24.25p
16:47 200,000 @ 0.24p
16:28 10,000 @ 24.14p
16:27 20,000 @ 24.43p
16:26 5,000 @ 24.13p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page